Cleared Traditional

PureLift GLOW (K243587) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K243587 · Xtreem Pulse, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2025
Decision
106d
Days
Class 2
Risk

K243587 is an FDA 510(k) clearance for the PureLift GLOW. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Xtreem Pulse, LLC (New York, US). The FDA issued a Cleared decision on March 6, 2025 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Xtreem Pulse, LLC devices

Submission Details

510(k) Number K243587 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 20, 2024
Decision Date March 06, 2025
Days to Decision 106 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 148d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 50
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K243587.
Microcurrent Facial Device (CEC101, EE0101, EEI101)
K244004 · Shenzhen Dachi Communication Co., Ltd. · Jul 2025
SmartAppGuidedTM MicroCurrent Face-Lift Pen 6 in 1
K250361 · Geske Beauty Tech GmbH · May 2025
Préime DermaFacial (MicroT)
K243072 · EMA Aesthetics , Ltd. · Apr 2025
Myolight Microcurrent Handpiece
K243063 · Raja Trading Company, Inc. · Feb 2025
JMOON NouvelleSkin Facial Toning Device (M30U PR, M30U MW, M30U SG, M30U SK, M30U MP)
K243393 · Shenzhen Ulike Smart Electronics Co., Ltd. · Feb 2025
Medi Lift Mask
K244048 · Ya-Man, Ltd. · Jan 2025